Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Efficacy and Utility of Cxbladder Tests in the Identification of Low vs High Risk Patients and the Detection of Urothelial Carcinoma in Patients Presenting With Hematuria

NCT04943380 is registered in ClinicalTrials.gov with Pacific Edge Limited as lead sponsor.

NCT NCT04943380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04943380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Efficacy and Utility of Cxbladder Tests in the Identification of Low vs High Risk Patients and the Detection of Urothelial Carcinoma in Patients Presenting With Hematuria
Lead sponsor
Pacific Edge Limited
Phase
Observational
Overall status
Completed
Start date
November 8, 2019
Completion date
January 18, 2024
Enrollment
682 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hematuria, urothelial carcinoma